Acro Biomedical (ACBM) Tax Provisions (2018 - 2019)

Acro Biomedical (ACBM) recorded quarterly Tax Provisions of $9871.0 in Q3 2019, up 155.22% quarter-over-quarter from -$17877.0 in Q2 2019, and up 163.16% on a YoY basis from $3751.0 in Q3 2018.

Acro Biomedical (ACBM) Tax Provisions (2018 - 2019) Analysis & Trends

Acro Biomedical's Tax Provisions history runs 2 years deep, the most recent figure standing at $9871.0 for Q3 2019.

  • In Q3 2019, Tax Provisions rose 163.16% year-over-year to $9871.0; the TTM figure through Jun 2020 stood at $9871.0 (up 112.46% YoY), while the FY2019 annual figure was -$53130.0, changed N/A from the prior year.
  • Tax Provisions was $9871.0 for Q3 2019 at Acro Biomedical, up from -$17877.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $59917.0 in Q2 2018 to a low of -$45124.0 in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn - -
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn - -
3 Berto Acquisition 311.56 Mn 311.56 Mn - -
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -
5 Centurion Acquisition 310.21 Mn 310.21 Mn - -
6 WEN Acquisition 309.15 Mn 309.15 Mn - -
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn - -
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn - -
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn - -
10 Acro Biomedical - - - -

Historic Data

Download Data
DateValue
Sep 30, 2019 9,871.00
Jun 30, 2019 -17,877.00
Mar 31, 2019 -45,124.00
Dec 31, 2018 -19,941.00
Sep 30, 2018 3,751.00
Jun 30, 2018 59,917.00
Mar 31, 2018 28,559.00